Cannabis litigation landscape; plummeting smartphone sales; Nokia offers arbitration to Oppo; quarterly litigation report; Deutsche Telekom on EPO transparency; plus much more
Everything we covered on IAM over the last seven days – and all you need to know from the global IP market to set yourself up for the start of another busy week
MONDAY 06 February
IAM’s lowdown on the fast-evolving cannabis patent dispute landscape. Read more here
Haynes and Boone bags most wins for PTAB petitioners while McKool Smith scores for patentees. Read more here
TUESDAY 07 February
A Delaware jury has ordered Boston Scientific to pay $42 million in damages to the University of Texas and its licensee, TissueGen, for wilful infringement of a US patent. Read more here
Smartphone sales plummet causing pain for SEP licensors. Read more here
WEDNESDAY 08 February
IAM exclusive: Nokia makes arbitration offer to Oppo in bid to resolve 5G dispute. Read more here
Long read: Patent strategies for protecting bioinformatics inventions. Read more here
Oppo joins Via Licensing’s AAC patent pool. Read more here
THURSDAY 09 February
Patent litigation finance works: no wonder some want it curtailed. Read more here
Greater transparency needed at the EPO, says Deutsche Telekom’s patent chief. Read more here
In the latest IAM-Docket Navigator litigation report, we examine the drastic impact of US Patent and Trademark Office Director Kathi Vidal’s policies on discretionary denials. Read more here
FRIDAY 10 February
InterDigital patent found valid on appeal by UK court in Lenovo licensing spat. Read more here
Long read: In a preview of IAM’s upcoming special report we offer insights from industry-leading IP organisations on putting diversity initiatives into action. Read more here
SEP holders hotly contest Stout’s ‘SEP privateer’ report. Read more here
SATURDAY 11 February
Opinion: Authenticity is key when it comes to brand sustainability. Read more here